Search research articles
Contact Us
Filters
Showing results (221-230 of 231) with videos related to
Page
of 24
Sort By:
The Lancet. Haematology
|
April 28, 2022
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies
Gita Thanarajasingam, Lori M Minasian, Vishal Bhatnagar, et al.
Nature Communications
|
September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Cirino Botta, Cristina Perez, Marta Larrayoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Blood
|
July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
Ibai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.
Research Square
|
June 12, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)
Floris Chabrun, Daniel Schwartz, Susanna Gentile, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2024
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
Aina Oliver-Caldes, Marta Español-Rego, Aintzane Zabaleta, et al.
Hemasphere
|
May 27, 2022
The EHA Research Roadmap: Malignant Lymphoid Diseases
Martin Dreyling, Marc André, Nicola Gökbuget, et al.
Blood
|
January 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma
Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
Rosalinda Termini, David Žihala, Evangelos Terpos, et al.
The Lancet. Oncology
|
March 4, 2021
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Philippe Moreau, Shaji K Kumar, Jesús San Miguel, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 231) with videos related to
Sort By:
Page
of 24
The Lancet. Haematology
|
April 28, 2022
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies
Gita Thanarajasingam, Lori M Minasian, Vishal Bhatnagar, et al.
Nature Communications
|
September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Cirino Botta, Cristina Perez, Marta Larrayoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, et al.
Blood
|
July 22, 2020
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
Ibai Goicoechea, Noemi Puig, Maria-Teresa Cedena, et al.
Research Square
|
June 12, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)
Floris Chabrun, Daniel Schwartz, Susanna Gentile, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2024
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
Aina Oliver-Caldes, Marta Español-Rego, Aintzane Zabaleta, et al.
Hemasphere
|
May 27, 2022
The EHA Research Roadmap: Malignant Lymphoid Diseases
Martin Dreyling, Marc André, Nicola Gökbuget, et al.
Blood
|
January 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma
Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
Rosalinda Termini, David Žihala, Evangelos Terpos, et al.
The Lancet. Oncology
|
March 4, 2021
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Philippe Moreau, Shaji K Kumar, Jesús San Miguel, et al.
Page
of 24